Showing 66,001 - 66,020 results of 101,367 for search '(( 5 c decrease ) OR ( 5 ((we decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 2.19s Refine Results
  1. 66001

    Image_11_Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.tif by Liu Liu (512237)

    Published 2021
    “…The mechanism of S1P receptor agonists in treating psoriasis might be related to a decrease in the number of white blood cells, topical lymph node weight, interleukin-23 mRNA levels, and percentage of CD3<sup>+</sup> T cells (p<0.05). …”
  2. 66002

    Image_12_Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.tif by Liu Liu (512237)

    Published 2021
    “…The mechanism of S1P receptor agonists in treating psoriasis might be related to a decrease in the number of white blood cells, topical lymph node weight, interleukin-23 mRNA levels, and percentage of CD3<sup>+</sup> T cells (p<0.05). …”
  3. 66003

    Image_4_Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.tif by Liu Liu (512237)

    Published 2021
    “…The mechanism of S1P receptor agonists in treating psoriasis might be related to a decrease in the number of white blood cells, topical lymph node weight, interleukin-23 mRNA levels, and percentage of CD3<sup>+</sup> T cells (p<0.05). …”
  4. 66004

    Image_6_Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.tif by Liu Liu (512237)

    Published 2021
    “…The mechanism of S1P receptor agonists in treating psoriasis might be related to a decrease in the number of white blood cells, topical lymph node weight, interleukin-23 mRNA levels, and percentage of CD3<sup>+</sup> T cells (p<0.05). …”
  5. 66005

    Table_2_Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.docx by Liu Liu (512237)

    Published 2021
    “…The mechanism of S1P receptor agonists in treating psoriasis might be related to a decrease in the number of white blood cells, topical lymph node weight, interleukin-23 mRNA levels, and percentage of CD3<sup>+</sup> T cells (p<0.05). …”
  6. 66006

    Image_2_Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.tif by Liu Liu (512237)

    Published 2021
    “…The mechanism of S1P receptor agonists in treating psoriasis might be related to a decrease in the number of white blood cells, topical lymph node weight, interleukin-23 mRNA levels, and percentage of CD3<sup>+</sup> T cells (p<0.05). …”
  7. 66007

    Image_1_Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.tif by Liu Liu (512237)

    Published 2021
    “…The mechanism of S1P receptor agonists in treating psoriasis might be related to a decrease in the number of white blood cells, topical lymph node weight, interleukin-23 mRNA levels, and percentage of CD3<sup>+</sup> T cells (p<0.05). …”
  8. 66008

    Image_3_Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.tif by Liu Liu (512237)

    Published 2021
    “…The mechanism of S1P receptor agonists in treating psoriasis might be related to a decrease in the number of white blood cells, topical lymph node weight, interleukin-23 mRNA levels, and percentage of CD3<sup>+</sup> T cells (p<0.05). …”
  9. 66009

    Image_10_Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.tif by Liu Liu (512237)

    Published 2021
    “…The mechanism of S1P receptor agonists in treating psoriasis might be related to a decrease in the number of white blood cells, topical lymph node weight, interleukin-23 mRNA levels, and percentage of CD3<sup>+</sup> T cells (p<0.05). …”
  10. 66010

    Image_9_Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.tif by Liu Liu (512237)

    Published 2021
    “…The mechanism of S1P receptor agonists in treating psoriasis might be related to a decrease in the number of white blood cells, topical lymph node weight, interleukin-23 mRNA levels, and percentage of CD3<sup>+</sup> T cells (p<0.05). …”
  11. 66011

    Image_13_Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.tif by Liu Liu (512237)

    Published 2021
    “…The mechanism of S1P receptor agonists in treating psoriasis might be related to a decrease in the number of white blood cells, topical lymph node weight, interleukin-23 mRNA levels, and percentage of CD3<sup>+</sup> T cells (p<0.05). …”
  12. 66012

    Image_8_Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.tif by Liu Liu (512237)

    Published 2021
    “…The mechanism of S1P receptor agonists in treating psoriasis might be related to a decrease in the number of white blood cells, topical lymph node weight, interleukin-23 mRNA levels, and percentage of CD3<sup>+</sup> T cells (p<0.05). …”
  13. 66013

    Table_1_Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms.docx by Liu Liu (512237)

    Published 2021
    “…The mechanism of S1P receptor agonists in treating psoriasis might be related to a decrease in the number of white blood cells, topical lymph node weight, interleukin-23 mRNA levels, and percentage of CD3<sup>+</sup> T cells (p<0.05). …”
  14. 66014

    Schematic of the filtration setup and flowmeter device used in this study. by Corentin Fournier (5088941)

    Published 2024
    “…<p>We used overpressure filtration for plankton size-class filtration with three filters in series, (<i>i</i>) a 180-μm nylon net pre-filter to remove zooplankton and larger particles, and (<i>ii</i>) a 5.0-μm and (<i>iii</i>) a 0.2-μm pore-size polycarbonate membrane filter, in order to collect the nanoplankton and picoplankton, respectively, for DNA extraction. …”
  15. 66015
  16. 66016
  17. 66017
  18. 66018
  19. 66019
  20. 66020